FDA Warning Indicates Scrutiny Of Regenerative Health Cos.
By Dominick DiSabatino and Cortney Inman · June 6, 2024, 6:03 PM EDT
On May 21, the Center for Biologics Evaluation and Research, or CBER, at the U.S. Food and Drug Administration published a warning letter issued to Akan Biosciences Inc. for unresolved inspection...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login